
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LPS promotes the expression of PD‐L1 in gastric cancer cells through NF‐κB activation
Hui Li, Jun‐Quan Xia, Fangshi Zhu, et al.
Journal of Cellular Biochemistry (2018) Vol. 119, Iss. 12, pp. 9997-10004
Closed Access | Times Cited: 50
Hui Li, Jun‐Quan Xia, Fangshi Zhu, et al.
Journal of Cellular Biochemistry (2018) Vol. 119, Iss. 12, pp. 9997-10004
Closed Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi, Mengke Niu, Linping Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 445
Ming Yi, Mengke Niu, Linping Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 445
Helicobacter pylori Virulence Factors—Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment
Jacek Baj, Alicja Forma, Monika Sitarz, et al.
Cells (2020) Vol. 10, Iss. 1, pp. 27-27
Open Access | Times Cited: 257
Jacek Baj, Alicja Forma, Monika Sitarz, et al.
Cells (2020) Vol. 10, Iss. 1, pp. 27-27
Open Access | Times Cited: 257
Regulation of PD-L1 Expression by NF-κB in Cancer
Fabrizio Antonangeli, Ambra Natalini, Marina Chiara Garassino, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 247
Fabrizio Antonangeli, Ambra Natalini, Marina Chiara Garassino, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 247
Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
Yaohui Gao, Dexi Bi, Ruting Xie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 166
Yaohui Gao, Dexi Bi, Ruting Xie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 166
High fat diet, gut microbiome and gastrointestinal cancer
Yao Tong, Huiru Gao, Qiuchen Qi, et al.
Theranostics (2021) Vol. 11, Iss. 12, pp. 5889-5910
Open Access | Times Cited: 127
Yao Tong, Huiru Gao, Qiuchen Qi, et al.
Theranostics (2021) Vol. 11, Iss. 12, pp. 5889-5910
Open Access | Times Cited: 127
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
Nasim Ebrahimi, Al‐Hasnawi Rasool Riyadh Abdulwahid, Atena Mansouri, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 26
Nasim Ebrahimi, Al‐Hasnawi Rasool Riyadh Abdulwahid, Atena Mansouri, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 26
The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 22
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 22
Helicobacter pylori and gastric cancer: mechanisms and new perspectives
Yantao Duan, Yonghu Xu, Yi Dou, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Yantao Duan, Yonghu Xu, Yi Dou, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Regulation of PD-L1 expression in cancer and clinical implications in immunotherapy.
Xiaoli Ju, Heng Zhang, Zidi Zhou, et al.
PubMed (2020) Vol. 10, Iss. 1, pp. 1-11
Closed Access | Times Cited: 95
Xiaoli Ju, Heng Zhang, Zidi Zhou, et al.
PubMed (2020) Vol. 10, Iss. 1, pp. 1-11
Closed Access | Times Cited: 95
Dysbiosis of gut microbiota in patients with esophageal cancer
Yali Deng, Derong Tang, Pan‐Fei Hou, et al.
Microbial Pathogenesis (2020) Vol. 150, pp. 104709-104709
Closed Access | Times Cited: 75
Yali Deng, Derong Tang, Pan‐Fei Hou, et al.
Microbial Pathogenesis (2020) Vol. 150, pp. 104709-104709
Closed Access | Times Cited: 75
NF-κB and Its Role in Checkpoint Control
Annika Betzler, Marie‐Nicole Theodoraki, Patrick J. Schuler, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3949-3949
Open Access | Times Cited: 73
Annika Betzler, Marie‐Nicole Theodoraki, Patrick J. Schuler, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3949-3949
Open Access | Times Cited: 73
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim, Helena Kupcová Skalníková, Jana Čížková, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Chahrazed Mekadim, Helena Kupcová Skalníková, Jana Čížková, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
Ching‐Hung Hsieh, Cheng-Zhe Jian, Liang‐In Lin, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 294-294
Open Access | Times Cited: 44
Ching‐Hung Hsieh, Cheng-Zhe Jian, Liang‐In Lin, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 294-294
Open Access | Times Cited: 44
PD-L1: expression regulation
Yujie Zhou, Guoli Li, Jiyin Wang, et al.
Blood Science (2023) Vol. 5, Iss. 2, pp. 77-91
Open Access | Times Cited: 30
Yujie Zhou, Guoli Li, Jiyin Wang, et al.
Blood Science (2023) Vol. 5, Iss. 2, pp. 77-91
Open Access | Times Cited: 30
Infiltration to infection: key virulence players of Helicobacter pylori pathogenicity
Arghyadeep Bhattacharjee, Om Saswat Sahoo, Ahana Sarkar, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 345-384
Closed Access | Times Cited: 9
Arghyadeep Bhattacharjee, Om Saswat Sahoo, Ahana Sarkar, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 345-384
Closed Access | Times Cited: 9
Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses
Ruiyi Deng, Huiling Zheng, Hongzhen Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Ruiyi Deng, Huiling Zheng, Hongzhen Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Role of regulation of PD-1 and PD-L1 expression in sepsis
Teng Zhang, Yujing Li, Tao Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Teng Zhang, Yujing Li, Tao Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Isak W. Tengesdal, Charles A. Dinarello, Carlo Marchetti
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108545-108545
Closed Access | Times Cited: 17
Isak W. Tengesdal, Charles A. Dinarello, Carlo Marchetti
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108545-108545
Closed Access | Times Cited: 17
All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer
Connor J. Hughes, Christopher P Alderman, Arthur Wolin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189098-189098
Closed Access | Times Cited: 6
Connor J. Hughes, Christopher P Alderman, Arthur Wolin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189098-189098
Closed Access | Times Cited: 6
Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways
Zhiyan Ruan, Minhua Liang, Ling Shang, et al.
Pancreatology (2021) Vol. 21, Iss. 3, pp. 630-641
Closed Access | Times Cited: 37
Zhiyan Ruan, Minhua Liang, Ling Shang, et al.
Pancreatology (2021) Vol. 21, Iss. 3, pp. 630-641
Closed Access | Times Cited: 37
Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy
Jiashe Chen, Zaigang Zhou, Chunjuan Zheng, et al.
Carbohydrate Polymers (2021) Vol. 277, pp. 118869-118869
Closed Access | Times Cited: 37
Jiashe Chen, Zaigang Zhou, Chunjuan Zheng, et al.
Carbohydrate Polymers (2021) Vol. 277, pp. 118869-118869
Closed Access | Times Cited: 37
RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion
Yanyan Zhang, Shuyi Zhu, Yuanyuan Du, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 27
Yanyan Zhang, Shuyi Zhu, Yuanyuan Du, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 27
Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases
Amke C. Beenen, Tatjana Sauerer, Niels Schaft, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8599-8599
Open Access | Times Cited: 24
Amke C. Beenen, Tatjana Sauerer, Niels Schaft, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8599-8599
Open Access | Times Cited: 24
Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development
Hsiang‐Wei Huang, Cheng‐Chih Chang, Chia‐Siu Wang, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 67-67
Open Access | Times Cited: 28
Hsiang‐Wei Huang, Cheng‐Chih Chang, Chia‐Siu Wang, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 67-67
Open Access | Times Cited: 28
NCX1 coupled with TRPC1 to promote gastric cancer via Ca2+/AKT/β-catenin pathway
Hanxing Wan, Nannan Gao, Wei Lu, et al.
Oncogene (2022) Vol. 41, Iss. 35, pp. 4169-4182
Open Access | Times Cited: 21
Hanxing Wan, Nannan Gao, Wei Lu, et al.
Oncogene (2022) Vol. 41, Iss. 35, pp. 4169-4182
Open Access | Times Cited: 21